An under-the-skin, self-administered version of Saphnelo (anifrolumab-fnia) could soon allow people with systemic lupus erythematosus (SLE) to manage their condition at home with the same effectiveness as clinical infusions. According to AstraZeneca, the new subcutaneous formulation provides efficacy comparable to the approved intravenous formulation while significantly reducing the…
Information about lupus
About
Lupus is an autoimmune inflammatory disease that can affect multiple systems in the body.
Causes
While the cause of lupus is often unknown, it is possibly due to a combination of genetics and the environment.
Symptoms
Lupus affects people in different ways, and symptoms vary among patients. Symptoms come and go during periods called flares.